Ahead of the Helix: GenomeWeb.com Highlights
Gunnar Weikert says: Unlike in America, European technological innovations rarely translate into successful, high-value products. Until now. The people behind the EITec believe that we can get the great minds in Europes ivory towers to come down and begin making significant contributions to science, business, the economy, and ultimately to millions of people.
Find TrendSpotter: Europeans Look to Merge Research and Business Like Les Americains by searching: Gunnar
Given the relatively fractured nature of the sector, companies seeking to grow may find that acquiring complementary technologies makes far more sense than trying to build complex instrumentation on their own. For entrepreneurs at some of the smaller companies, an acquisition may be their last chance to hit pay dirt.
Find Proteomics Sector Shows First Symptoms of M&A Fever by searching: symptoms
Ego Wins Out
Today we basically established GeneProts leadership in the role of proteomics. Cedric Loiret-Bernal
Find Backed by Compaq, Bruker, and Novartis, GeneProt Opens Industrial-Scale Proteomics Facility by searching: GeneProt
Desperately Seeking Anyone
It didnt seem to matter that the new Perlegen executive has no job experience or background in life sciences. Everyone knows how hard it is to find executives with one foot in biology and the other in information systems. Everybody is looking for the same people, says Ellen Clark of Clark Executive Search. Job seekers know that its a buyers market, and many are demanding hefty compensation packages.
Find Despite Cool Economy, Genomics Companies Still Struggling to Fill Positions by searching: positions
Crouching Bear, Hidden Bull
Its a bears holiday; they are roaming freely on Wall Street. Occasionally, a bull pokes its head out and makes a run for it. But he goes it alone, no thundering herds! Ira Leiderman
Find TrendSpotter: Private Offerings Offer Hope to Cash-Strapped Firms by searching: cash-strapped
Go East, Young Man
As Japan lunges into its government-supported genomics effort, Western genomics companies have lately been showing signs they are turning eastward to seize the new market opportunities. AP Biotech said its sales of instruments and reagents to Japan and throughout Asia had increased enough to offset the effects of a weak North American market for sequencers.
Find As Japan Blasts into Genomics, Western Companies Look East for Revenues by searching: Japan
The Mighty Jungle
Approximately 20 percent of the San Diego-based Trega Biosciences was let go in Lions plan to restructure the operation as an R&D center of excellence. Lion CEO Friedrich von Bohlen said the restructuring falls in line with Lions goal to establish a horizontal enterprise-wide informatics system that combines biology, chemistry, and preclinical research with clinical data and information.
Find Lion Firms Up Post-Trega Plan; Layoffs, New Hires Mark Cheminformatics Focus by searching: Trega
BioArray News.com Highlights
In the inaugural issue of BioArray News, a weekly global newsletter on the biochip/microarray market, youll find an interview with Affymetrix CEO Steve Fodor on his companys strategy for staying on top. Therell be a Q&A with a microarray user from a leading pharma company, and well introduce readers to new microarray companies breaking into the sector. Also, in a special feature unique to this issue: charts comparing all of the specialty microarrays available and the top players in the field.